The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).

REDWOOD CITY, Calif. & VENLO, the Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN, Frankfurt Prime Standard: QIA) today announced the launch of Ingenuity Pathway Analysis (IPA) Interpret, a new ...

miRNA dysregulation of AGE/RAGE signaling in the context of MetS and its comorbidities seems significant but insufficiently studied. Even with a deductive approach, one cannot help but notice that ...